Diabetes, depressive symptoms, and inflammation in older adults: Results from the Health, Aging, and Body Composition Study

Journal of Psychosomatic Research

Volumn 75, Issue 5, 2013, Pages 419-424

  Doyle, Todd A ^a   de Groot, Mary ^b   Harris, Tamara ^c   Schwartz, Frank ^d   Strotmeyer, Elsa S ^e   Johnson, Karen C ^f   Kanaya, Alka ^g  

^a OHIO UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d OHIO UNIVERSITY   (United States)

^e UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C reactive protein; Depressive symptoms; Diabetes; Inflammation; Interleukin 6; Tumor necrosis factor

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ARTICLE; BODY COMPOSITION; COMORBIDITY; COMPARATIVE STUDY; DEPRESSION; DISEASE ASSOCIATION; EVIDENCE BASED PRACTICE; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

C-REACTIVE PROTEIN; DEPRESSIVE SYMPTOMS; DIABETES; INFLAMMATION; INTERLEUKIN-6; TUMOR NECROSIS FACTOR-Α;

AGED; AGING; BIOLOGICAL MARKERS; BODY COMPOSITION; C-REACTIVE PROTEIN; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; TUMOR NECROSIS FACTOR-ALPHA; UNITED STATES; UP-REGULATION;

EID: 84886949470     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2013.08.006     Document Type: Article

References (63)

1. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001, 24:1069-1078.
2. Gavard JA, Lustman PJ, Clouse RE Prevalence of depression in adults with diabetes: an epidemiological evaluation. Diabetes Care 1993, 16:1167-1178.
3. de Groot M, Doyle T, Hockman E, Wheeler C, Pinkerman B, Shubrook J, et al. Depression among type 2 diabetes rural Appalachian clinic attendees. Diabetes Care 2007, 30:1602-1604.
4. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000, 23:934-942.
5. de Groot M, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001, 63:619-630.
6. Ciechanowski PS, Katon WJ, Russo JE Depression and diabetes. Impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000, 160:3278-3285.
7. Katon W., Von Korff M., Ciechanowski P., Russo J., Lin E., Simon G., et al. Behavioral and clinical factors associated with depression among individuals with diabetes. Diabetes Care 2004, 27:914-920.
8. Katon W, Rutter C, Simon G, Lin EB, Ludman E, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 2005, 28:2668-2672.
9. Stuart MJ, Baune BT Depression and type 2 diabetes: inflammatory mechanisms of a psychoneuroendocrine co-morbidity. Neurosci Biobehav Rev 2012, 36:658-676.
10. Pickup JC Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004, 27:813-823.
11. Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A Atherosclerosis 2003, 166:387-394.
12. Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, et al. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism 2002, 51:743-749.
13. Mishima Y, Kuyama A, Tada A, Takahashi K, Ishioka T, et al. Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with type 2 diabetes mellitus. Diabetes Res Clin Pract 2001, 52:119-123.
14. Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H Relation between plasma tumor necrosis factor-α and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1998, 18:1199-1202.
15. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, et al. Serum levels of tumor necrosis factor-α are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998, 83:859-862.
16. Winkler G, Salamon F, Salamon D, Speer G, Simon K, et al. Elevated serum tumor necrosis factor-alpha levels can contribute to the insulin resistance in type II (non-insulin-dependent) diabetes and in obesity. Diabetologia 1998, 41:860-862.
17. Hogue J, Lamarche B, Tremblay AJ, Bergeron J, Gagne C Differential effect of atorbastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus. Metabolism 2008, 57:380-386.
18. Muhlestein JB, May HT, Jensen JR, Horne BD, Lanman RB The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia. The DIACOR Study. JACC 2006, 48:396-401.
19. Tan SA, Tan LG, Berk LS Effects of rosuvastatin and pioglitazone on monocyte chemotactic protein-1, cytokines, C-reactive protein and hdl-cholesterol in diabetic dyslipidemia. J Clin Lipidol 2007, 1:160-161.
20. Pereira FO, Frode TA, Medeiros YS Evaluation of tumour necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites, and lipids as inflammatory markers in type 2 diabetes mellitus. Mediators Inflamm 2006, 1-7.
21. Bullo M, Garcia-Lorda P, Megias I, Salas-Salbado J Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 2003, 11:525-531.
22. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys, et al. Association between C-reactive protein and features of the metabolic syndrome. Diabetes Care 2000, 23:1835-1839.
23. Coppola G, Corrado E, Muratori I, Tantillo R, Vitale G, et al. Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM. Int J Cardiol 2006, 106:16-20.
24. Corrado E, Rizzo M, Muratori I, Coppola G, Novo S Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. Arch Med Res 2006, 37:1004-1009.
25. Wakabayashi I, Masuda H Association of acute-phase reactants with arterial stiffness in patients with type 2 diabetes mellitus. Clin Chim Acta 2006, 365:230-235.
26. Yu H, Sheu WH, Song Y, Liu H, Lee W C-reactive protein and risk factors for peripheral vascular disease in subjects with type 2 diabetes mellitus. Diabet Med 2004, 21:336-341.
27. de Jager J, Dekker JM, Kooy A, Kostense PJ, Nijpels G, et al. Endothelial dysfunction and low-grade inflammation explain much of the excess cardiovascular mortality in individuals with type 2 diabetes: the Hoorn Study. Arterioscler Thromb Vasc Dis 2006, 26:1086-1093.
28. Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, et al. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes 2006, 55:1133-1140.
29. Stehouwer CDA, Gall M, Twisk JWR, Knudsen E, Emeis JJ, et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Diabetes 2002, 51:1157-1165.
30. Raison CL, Capuron L, Miller AH Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31.
31. Ruhé HG, Mason NS, Schene AH Mood is indirectly related to serotonin, norepinephrine and dopamine levels on human: a meta-analysis of monoamine depletion studies. Mol Psychiatry 2007, 12:331-359.
32. Dantzer R, O'Connor JC, Freund GC, Johnson RW, Kelley KW From inflammation to sickness and depression: when the immune system subjugates the brain. Nature 2008, 9:46-57.
33. Jansen ASP, Schmidt ED, Voorn P, Tilders FJH Substance induced plasticity in noradrenergic innervation of paraventricular hypothalamic nucleus. Eur J Neurosci 2003, 17:298-306.
34. Irwin MR, Miller AH Depressive disorders and immunity: 20years of progress and discovery. Brain Behav Immun 2007, 25:374-383.
35. Tuglu C, Kara HS, Caliyurt O, Vardar E, Abay E Increased tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 2003, 170:429-433.
36. Lanquollon S, Krieg JC, Bening-Abu-Shanch U, Vedder H Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2003, 22:370-379.
37. Sluzewaska A, Rybakowski J, Bosmans E, Sobieska M, Berghmans R, et al. Indicators of immune activation in major depression. Psychiatry Res 1996, 64:161-167.
38. Maes M, Bosmans E, de Jongh R, Kenis G, Vandoolaeghe E, et al. Increased serum IL-6 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 1997, 9:853-858.
39. Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the prospective epidemiological study of myocardial infarction (PRIME). Circulation 2005, 111:2299-2305.
40. Ladwig K, Marten-Mittag B, Lowel H, Doring A, Koenig W C-reactive protein, depressed mood, and the prediction of coronary heart disease in initially healthy men: results from the MONICA-KORA Augsburg Cohort Study 1984-1998. Eur Heart J 2005, 26:2537-2542.
41. Ferketich AK, Ferguson JP, Binkley PF Depressive symptoms and inflammation among heart failure patients. Am Heart J 2005, 150:132-136.
42. Miller GE, Freedland KE, Duntley S, Carney RM Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol 2005, 95:317-321.
43. Health ABC. National Institute on Aging; 2010. http://www.nia.nih.gov/ResearchInformation/ScientificResources/HealthABCDescription.htm.
44. de Rekeneire N, Peila R, Ding J, Colbert LH, Shorr RI, et al. Diabetes, hyperglycemia, and inflammation in older individuals. Diabetes Care 2006, 29:1902-1908.
45. Radloff LS The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977, 1:385-401.
46. Beekman ATF, Deeg DJH, van Limbeek J, Braam AW, de Vries MZ, et al. Criterion validity of the center for epidemiologic studies depression scale (CES-D): results form a community-based sample of older subjects in the Netherlands. Psychol Med 1997, 27:231-235.
47. Haringsma R, Engels GI, Beekman ATF, Spinhoven P The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology. Int J Geriatr Psychiatry 2004, 19:558-563.
48. Blank K, Gruman C, Robison JT Case-finding for depression in elderly people: balancing ease of administration with validity in varied treatment settings. J Gerontol A Biol Sci Med Sci 2004, 59:378-384.
49. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991, 1:263-276.
50. Pahor M, Chrischilles EA, Guralnik JM, Brown SL, Wallace RB, et al. Drug data coding and analysis in epidemiologic studies. Eur J Epidemiol 1994, 10:405-411.
51. Strotmeyer SE, Cauley JA, Orchard TJ, Steenkiste AR, Dorman JS Middle-aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women. Diabetes Care 2006, 29:306-311.
52. SAS Institute Version 9.1e 2003, [Cary, NC].
53. O'Riordain MG, Ross J, Fearon KCH, Maingay J, Farouk M, et al. Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol 1995, 269:E323-E330.
54. Tan K C, Chow W S, Tam S, Bucala R, Betteridge J Association between acute-phase reactants and advanced glycation end products in type 2 diabetes. Diabetes Care 2004, 27:223-228.
55. Florez H, Castillo-Florez S, Mendez A, Casanova-Romero P, Larreal-Urdaneta C, Lee D, et al. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res Clin Pract 2006, 71:92-100.
56. Chagas CEA, Borges MC, Martini LA, Rogero MM Focus on vitamin D, inflammation and type 2 diabetes. Nutrients 2012, 4:52-67.
57. Dandona P, Aljada A, Bandyopadhyay A Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004, 25:4-7.
58. Lyngdoh T, Vollenweider P, Waeber G, Marques-Vidal P Association of statins with inflammatory cytokines: a population-based Colaus Study. Atherosclerosis 2011, 219:253-258.
59. Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ Cumulative depression episodes predict later C-reactive protein levels: a prospective analysis. Biol Psychiatry 2012, 71:15-21.
60. Jamal M, Van der Does WAJ, Cuijpers P, Penninx B W J H Association of smoking and nicotine dependence with severity and course of symptoms in patient with depressive or anxiety disorder. Drug Alcohol Depend 2012, 126:138-146.
61. Khantzian E J, Albanese M J Understanding addiction as self-medication: finding hope behind the pain 2008, Rowman & Littlefield, Lanham, MD.
62. Kerse N, Falloon K, Moyes SA, Hayman KJ, Dowell T, Kolt GS, et al. DeLLITE depression in late life: an intervention trial of exercise. Design and recruitment of a randomized controlled trial. BMC Geriatr 2008, 8:12.
63. Harman JS, Veazie PJ, Lyness JM Primary care physician office visits for depression by older Americans. J Gen Intern Med 2006, 21:926-930.